-
Repsol says profit more than triples on higher oil prices
-
Renault says sales stalled in first half
-
TotalEnergies says profit doubled on Mideast war
-
EasyJet says profits nosedive on Mideast war
-
Giant swing on Swiss peak aims to boost summer tourism as Alps warm
-
Modi vows punishment for exam fraud fuelling India protests
-
ASEAN to call for open straits as US-Iran war casts shadow
-
Six candidates in race to lead UN set for televised debate
-
AI catches up with humans to score 100% at top maths contest
-
Comic-Con kicks off with Marvel's return
-
South Korea election office raided in fake turnout figures probe: investigators
-
Dutch riders dreaming of crazy party corner of Alpe d'Huez
-
Killer whales: orcas blow fish to bits 'for fun', study finds
-
Houthis target Red Sea shipping as US hits Iran
-
Deadly wildfires force thousands from homes in parts of Europe
-
Record-equalling Red Sox streak halted at 15 wins
-
Tech bounce lifts Asia stocks, oil extends gains on US-Iran fears
-
Messi-less Miami beat Fire 3-2 to spoil Lewandowski's MLS debut
-
Surrounded by militias, Sudanese fear endless cycle of war
-
Mercedes expect Hungary challenge from Hamilton and Ferrari
-
Commonwealth Games 'where champions are made' despite slimmed down model, argues president
-
In Ghana, one man's race to save critically endangered fish
-
Trump family project in Albania has already caused 'irreparable' damage: NGOs
-
Wilson captain, Slipper absent in Kiss's first Wallabies squad
-
Bollywood blast master keeps it real with fire and fury
-
New Mideast fighting puts eurozone rate-setters on alert
-
Tearful fights, edible offerings: A glimpse into the Maradona trial
-
Venezuelans search for animal companions lost in the quakes
-
What's the deal with peptides? The hyped market under US review
-
Argentine Football Association says US did not detain its president
-
Tesla shares fall as Musk touts ambitious -- and costly -- plans
-
June heatwave cost UK economy more than £1bn: study
-
Houthis claim Red Sea tanker strikes as US hits Iran again
-
Google-parent Alphabet beats expectations, cloud revenue nearly doubles
-
Wildfires ravage parts of southern France, Italy and Spain
-
US announces civilian nuclear deal with Saudi Arabia
-
Alphabet beats expectations in second quarter, cloud revenue nearly doubles
-
Tesla shares dip after profit misses expectations
-
Trump threatens Iran infrastructure, Tehran vows 'eye for eye'
-
Red Sox tie club record with 15th straight MLB win
-
US teen withdraws lawsuit against Meta over social media addiction
-
US eyes offshore nuclear reactors
-
Lebanon PM says Beirut working for 'complete Israeli withdrawal'
-
The Sterling Announces Luxury Cocktail Lounge Concept and Investor Showcase in Orlando
-
EU conditionally clears Paramount bid for Warner Bros.
-
Inter Miami signs Brazil veteran Casemiro but MLS probes deal
-
Philipsen snaps 'horrible' drought with Tour de France stage 17 victory
-
White House accuses China's Moonshot of stealing Anthropic AI
-
US trial of Venezuela's Maduro set for June 2027
-
Pogacar sweating on Yates's fitness ahead of Tour Queen stage
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence
Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use
HAYWARD, CALIFORNIA / ACCESS Newswire / July 29, 2025 / Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use. The media and chambers were part of Biolog's acquisition of Anaerobe Systems earlier this year with the objective of bringing class-leading tools for microbiology to the rapidly growing clinical, microbiome, and agricultural markets.
Today, Biolog's TruPRAS™ media is the only commercial media manufactured under true pre-reduced, anaerobically sterilized conditions, preventing the formation of harmful byproducts that can be toxic to anaerobic organisms. This line of media products, which has been approved for In Vitro Diagnostic (IVD) use by the USA FDA for years, has now also achieved CE marking under the requirements of the EU IVDR regulation 2017/746. With zero recalls or field actions throughout their extensive history, these products enable transport of specimens and growth of fastidious anaerobes that play important roles in disease pathology - supporting clinical diagnostics in medical laboratories.
"The IVDR/CE mark is a major milestone that recognizes the high standard of our anaerobic media and its value in supporting critical diagnostic workflows," said Robert Wicke, CEO at Biolog. "We're proud that clinical labs throughout Europe can now benefit from the same reliable performance that researchers and clinicians in the U.S. have trusted for decades."
Biolog's anaerobic chambers have also received the CE mark, affirming their safety and performance for use in any research settings throughout the world. With unique InstaSleeve™ technology, these ergonomic, gloveless chambers offer superior processing dexterity while working in a fully anaerobic environment and are a preferred tool for microbiologists in both clinical and academic settings. In addition, Biolog is releasing an upgrade to enable hypoxic or microaerophilic conditions in the same chamber, for organisms that require specific, low concentrations of oxygen to thrive.
"This dual achievement reinforces Biolog's commitment to advancing global access to high-quality tools for anaerobic microbiology," said Wicke. "Whether you're working with challenging clinical isolates or conducting fundamental research, Biolog now provides dependable CE-marked solutions that meet your needs."
About Biolog
Biolog offers tools, services, and support for comprehensive cellular characterization and multi-omic identification of bacteria, yeast, and fungi. Our products also enable phenotypic profiling of microbial and mammalian cells for a range of applications, including supporting the culture of fastidious anaerobes with our line of gloveless chambers and pre-reduced media. Learn more at biolog.com
Contact Information
John Proctor, Ph.D.
CCO
[email protected]
(408)306-0414
SOURCE: Biolog, Inc.
View the original press release on ACCESS Newswire
H.Weber--VB